fusius vasta Forssk的GC-MS分析、综合生物学分析、分子对接和ADMET研究。正己烷提取。

IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Future Science OA Pub Date : 2025-12-01 Epub Date: 2025-07-06 DOI:10.1080/20565623.2025.2527021
Hanan Y Aati, Abdul Rauf, Jawahir Al-Qatani, Bilal Ahmad Ghalloo, Areej Al-Tweel, Mona Khwery, Huma Rao, Muhammad Sajid-Ur-Rehman, Kashif-Ur-Rehman Khan
{"title":"fusius vasta Forssk的GC-MS分析、综合生物学分析、分子对接和ADMET研究。正己烷提取。","authors":"Hanan Y Aati, Abdul Rauf, Jawahir Al-Qatani, Bilal Ahmad Ghalloo, Areej Al-Tweel, Mona Khwery, Huma Rao, Muhammad Sajid-Ur-Rehman, Kashif-Ur-Rehman Khan","doi":"10.1080/20565623.2025.2527021","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong><i>Ficus vasta</i> Forssk. is a valuable but relatively less explored medicinal and edible plant. This study focused on analyzing the biochemical properties, molecular docking, and ADMET profiling of its n-hexane extract (NHFV).</p><p><strong>Materials and methods: </strong>Phytochemical screening was performed using GC-MS and total bioactive content assays (TPC, TFC, and TTC). Antioxidant potential (NOS and TAC), antiurease, antityrosinase, and hemolytic activities were also assayed. Molecular docking was performed for GC-MS identified ligands against urease and tyrosinase. ADMET investigation was performed to assess drug-likeness and safety profiles.</p><p><strong>Results: </strong>NHFV showed significant concentration of TPC (48.01 ± 0.73 mg GA.Eq.g<sup>-1</sup>), TFC (65.33 ± 0.67 mg QU.Eq.g<sup>-1</sup>), and TTC (3.45 ± 0.31 mg TA.Eq.g<sup>-1</sup>). GC-MS analysis identified 43 phytochemicals. Antioxidant assays revealed 91.34 ± 0.86 mg AA.Eq.g<sup>-1</sup> NOS and 72.90 ± 0.10 mg AA.Eq.g<sup>-1</sup> TAC activity. The extract showed 4.64 ± 0.08% hemolysis, 60.20 ± 1.39% urease, and 75.61 ± 0.64% tyrosinase inhibition. Docking results revealed Cycloartenol (-8.2 kcal/mol) and Lupeol acetate (-8.3 kcal/mol) as potent inhibitors, surpassing standard agents.</p><p><strong>Conclusion: </strong>NHFV possesses prominent antioxidant, antiulcer, and skin-whitening potential. Molecular docking and ADMET data support its therapeutic relevance and potential for future drug design.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2527021"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233824/pdf/","citationCount":"0","resultStr":"{\"title\":\"GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of <i>Ficus vasta</i> Forssk. <i>n</i>-hexane extract.\",\"authors\":\"Hanan Y Aati, Abdul Rauf, Jawahir Al-Qatani, Bilal Ahmad Ghalloo, Areej Al-Tweel, Mona Khwery, Huma Rao, Muhammad Sajid-Ur-Rehman, Kashif-Ur-Rehman Khan\",\"doi\":\"10.1080/20565623.2025.2527021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong><i>Ficus vasta</i> Forssk. is a valuable but relatively less explored medicinal and edible plant. This study focused on analyzing the biochemical properties, molecular docking, and ADMET profiling of its n-hexane extract (NHFV).</p><p><strong>Materials and methods: </strong>Phytochemical screening was performed using GC-MS and total bioactive content assays (TPC, TFC, and TTC). Antioxidant potential (NOS and TAC), antiurease, antityrosinase, and hemolytic activities were also assayed. Molecular docking was performed for GC-MS identified ligands against urease and tyrosinase. ADMET investigation was performed to assess drug-likeness and safety profiles.</p><p><strong>Results: </strong>NHFV showed significant concentration of TPC (48.01 ± 0.73 mg GA.Eq.g<sup>-1</sup>), TFC (65.33 ± 0.67 mg QU.Eq.g<sup>-1</sup>), and TTC (3.45 ± 0.31 mg TA.Eq.g<sup>-1</sup>). GC-MS analysis identified 43 phytochemicals. Antioxidant assays revealed 91.34 ± 0.86 mg AA.Eq.g<sup>-1</sup> NOS and 72.90 ± 0.10 mg AA.Eq.g<sup>-1</sup> TAC activity. The extract showed 4.64 ± 0.08% hemolysis, 60.20 ± 1.39% urease, and 75.61 ± 0.64% tyrosinase inhibition. Docking results revealed Cycloartenol (-8.2 kcal/mol) and Lupeol acetate (-8.3 kcal/mol) as potent inhibitors, surpassing standard agents.</p><p><strong>Conclusion: </strong>NHFV possesses prominent antioxidant, antiulcer, and skin-whitening potential. Molecular docking and ADMET data support its therapeutic relevance and potential for future drug design.</p>\",\"PeriodicalId\":12568,\"journal\":{\"name\":\"Future Science OA\",\"volume\":\"11 1\",\"pages\":\"2527021\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233824/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Science OA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/20565623.2025.2527021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2025.2527021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:无花果树。是一种有价值但相对较少开发的药用和食用植物。本研究主要分析了其正己烷提取物(NHFV)的生化特性、分子对接和ADMET谱分析。材料和方法:采用GC-MS和总生物活性含量测定(TPC, TFC和TTC)进行植物化学筛选。测定抗氧化潜能(NOS和TAC)、抗脲酶、抗酪氨酸酶和溶血活性。对GC-MS鉴定的脲酶和酪氨酸酶配体进行分子对接。进行ADMET调查以评估药物相似性和安全性。结果:NHFV中TPC(48.01±0.73 mg GA.Eq.g-1)、TFC(65.33±0.67 mg q. eq .g-1)、TTC(3.45±0.31 mg TA.Eq.g-1)浓度显著。GC-MS分析鉴定出43种植物化学物质。抗氧化水平为91.34±0.86 mg。g-1 NOS和72.90±0.10 mg AA.Eq。g-1 TAC活性。溶血率为4.64±0.08%,脲酶抑制率为60.20±1.39%,酪氨酸酶抑制率为75.61±0.64%。对接结果显示,环蒿烯醇(-8.2 kcal/mol)和鹿皮醇醋酸酯(-8.3 kcal/mol)是有效的抑制剂,优于标准药物。结论:NHFV具有显著的抗氧化、抗溃疡和美白作用。分子对接和ADMET数据支持其治疗相关性和未来药物设计的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of <i>Ficus vasta</i> Forssk. <i>n</i>-hexane extract.

GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of <i>Ficus vasta</i> Forssk. <i>n</i>-hexane extract.

GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of <i>Ficus vasta</i> Forssk. <i>n</i>-hexane extract.

GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of Ficus vasta Forssk. n-hexane extract.

Aims: Ficus vasta Forssk. is a valuable but relatively less explored medicinal and edible plant. This study focused on analyzing the biochemical properties, molecular docking, and ADMET profiling of its n-hexane extract (NHFV).

Materials and methods: Phytochemical screening was performed using GC-MS and total bioactive content assays (TPC, TFC, and TTC). Antioxidant potential (NOS and TAC), antiurease, antityrosinase, and hemolytic activities were also assayed. Molecular docking was performed for GC-MS identified ligands against urease and tyrosinase. ADMET investigation was performed to assess drug-likeness and safety profiles.

Results: NHFV showed significant concentration of TPC (48.01 ± 0.73 mg GA.Eq.g-1), TFC (65.33 ± 0.67 mg QU.Eq.g-1), and TTC (3.45 ± 0.31 mg TA.Eq.g-1). GC-MS analysis identified 43 phytochemicals. Antioxidant assays revealed 91.34 ± 0.86 mg AA.Eq.g-1 NOS and 72.90 ± 0.10 mg AA.Eq.g-1 TAC activity. The extract showed 4.64 ± 0.08% hemolysis, 60.20 ± 1.39% urease, and 75.61 ± 0.64% tyrosinase inhibition. Docking results revealed Cycloartenol (-8.2 kcal/mol) and Lupeol acetate (-8.3 kcal/mol) as potent inhibitors, surpassing standard agents.

Conclusion: NHFV possesses prominent antioxidant, antiulcer, and skin-whitening potential. Molecular docking and ADMET data support its therapeutic relevance and potential for future drug design.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信